Via Transportation Inc (VIA) Stock News

Via Transportation, Inc. faces a class action lawsuit alleging its September 2025 IPO offering documents were materially false and misleading. The company allegedly concealed declining revenue per customer and regulatory issues in Germany. Stock has dropped approximately 70% below the IPO price of $46 following successive negative earnings announcements. Investors with substantial losses have until August 10, 2026 to seek lead plaintiff status.

Rosen Law Firm, a leading investor rights law firm, has announced class action securities lawsuits against Via Transportation, Inc., GeneDx Holdings Corp., and BitGo Holdings, Inc. The Via lawsuit alleges that IPO registration documents contained false and misleading statements about the company's growth challenges and revenue decline. Investors who purchased shares during the class period may be eligible for compensation. The deadline to serve as lead plaintiff in the Via case is August 10, 2026.

Via Transportation, Inc. (NYSE: VIA) faces a securities fraud class action lawsuit alleging that company defendants made materially false statements and failed to disclose material adverse facts about declining Annual Run-Rate Revenue per customer and regulatory headwinds in Germany. The stock has fallen nearly 70% from its $46 IPO price in September 2025 to $14.12 by May 2026. Investors have until August 10, 2026 to file a lead plaintiff motion.

Via Transportation, Inc. faces a securities fraud class action lawsuit after its stock plummeted nearly 70% from its September 2025 IPO price of $46 to $14.12 by May 2026. The lawsuit alleges the company made materially false statements and failed to disclose that Annual Run-Rate Revenue per customer was declining and that regulatory issues in Germany would hinder its expansion strategy. Shareholders have until August 10, 2026 to file a lead plaintiff motion.

Robbins LLP has filed a class action lawsuit against Via Transportation, Inc. alleging the company misled investors in its September 2025 IPO regarding customer growth and revenue generation. The complaint claims Via failed to disclose declining Annual Run-Rate Revenue per customer and regulatory challenges in Germany. Stock price has fallen approximately 70% from the $46 IPO price to $14.12 following three disclosure events between November 2025 and May 2026.

A securities class action has been filed against Via Transportation, Inc. (NYSE: VIA) alleging that its September 2025 IPO registration statement concealed declining revenue metrics and German regulatory barriers. The stock fell from $46.00 at IPO to $14.12 by May 2026, representing a 69% loss. The lawsuit names Goldman Sachs, Morgan Stanley, Allen & Company, Wells Fargo Securities, and other underwriters for allegedly failing to conduct adequate due diligence on deteriorating growth metrics and market obstacles.

A securities fraud lawsuit has been filed against Via Transportation, Inc. following its September 2025 IPO at $46 per share. The company's stock has plummeted nearly 70% to $14.12 after disclosing declining revenue per customer and regulatory headwinds in Germany. Shareholders have until August 10, 2026 to file a lead plaintiff motion, with allegations that the company made materially false statements about its business prospects.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that the company's offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52. The deadline to serve as lead plaintiff is August 10, 2026.

A securities fraud class action lawsuit has been filed against Via Transportation, Inc. following its September 2025 IPO at $46 per share. The company failed to disclose declining Annual Run-Rate Revenue per customer and regulatory headwinds in Germany, leading to significant stock price declines. Via's stock has fallen nearly 70% from its IPO price to $14.12 as of May 2026. Shareholders have until August 10, 2026 to file a lead plaintiff motion.

The Schall Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) for securities fraud. The company allegedly made false and misleading statements about its business growth and financial performance during its September 2025 IPO. Via claimed durable revenue growth through its 'land and expand' strategy but was actually experiencing declining Annual Run-Rate Revenue (ARR) and growth obstacles. The company only disclosed regulatory pressures in Germany on May 12, 2026, causing investor losses. Investors who purchased securities during the IPO are encouraged to join the lawsuit before August 10, 2026.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52, and investors are encouraged to join the class action before the August 10, 2026 deadline to serve as lead plaintiff.

A class action lawsuit has been filed against Via Transportation, Inc. alleging that its September 2025 IPO offering documents were false and misleading. The complaint claims Via omitted information about declining growth and inability to expand in Germany. Following a March 2026 report questioning Via's business model, the stock fell 59.7% from its $46 IPO price to $18.51. Investors have until August 10, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Via Transportation, Inc. on behalf of shareholders who purchased stock in its September 2025 IPO at $46 per share. The company allegedly made materially false statements and failed to disclose that Annual Run-Rate Revenue per customer was declining and that regulatory issues in Germany would hinder its expansion strategy. Via's stock has fallen nearly 70% from the IPO price to $14.12 per share as of May 2026. Investors have until August 10, 2026 to file a lead plaintiff motion.

DBV Technologies announced the first participant screening in the THRIVE phase 2 clinical trial evaluating the efficacy and safety of VIASKIN® Peanut patch in infants aged 6-12 months with peanut allergies. The study aims to enable ad libitum peanut consumption through early intervention immunotherapy, building on positive results from earlier trials in older children.

DBV Technologies announced the first participant has been screened in the THRIVE Phase 2 clinical study evaluating the efficacy and safety of the VIASKIN® Peanut Patch in infants ages 6-12 months with peanut allergy. The study will assess whether the patch can enable ad lib (unrestricted) peanut consumption through epicutaneous immunotherapy (EPIT), building on positive results from earlier trials in older age groups.

OPTAVIA released research findings showing that clients using their Optimal Weight 5 & 1 Plan with coach support lost up to 10 times more weight and 17 times more fat compared to self-directed participants. The study highlights the importance of human coaching in weight management programs, with research indicating that higher retention rates directly correlate with better weight loss outcomes. OPTAVIA coaches complete a certification program and provide accountability and emotional support rather than clinical guidance.